Instead, the two medications often complement each othermetformin improves insulin sensitivity while semaglutide enhances insulin secretion and reduces appetite, leading to greater combined benefits for blood sugar control and weight loss
Gallbladder complications, including cholecystitis and cholelithiasis, have been reported in clinical monitoring
The drug, which Novo Nordisk calls simply the Wegovy pill, uses the same active ingredient - semaglutide - that powers the original Wegovy, along with its sister drug for diabetes, Ozempic
Together, they influence appetite, fullness, insulin response, and how efficiently your body manages glucose
[7] According to the World Health Organization, adult obesity has more than doubled since 1990
A significant risk associated with Ozempic is the development of gastroparesis, a medical condition characterized by the stomachs delayed emptying process